- Digital Health Startups
- Economics of Healthcare and Pharmaceuticals
- Forecasting for Drug Development Strategy
- Global Healthcare Strategy
- Healthcare Investment and Entrepreneurship
- Investing in Medical Technologies
- NYC Immersion Seminar: Creating Value in Healthcare Delivery
- Public Policy and the Healthcare Industry
- Strategy and Competition in Pharmaceuticals and Biotechnology
- The U.S. Healthcare Industry
- Transforming the Delivery of Healthcare Services
Healthcare and Pharmaceutical Management Program Students
Columbia Business School's Healthcare and Pharmaceutical Management Program prepares its students to enter a business world that is dramatically impacted by the complex and evolving global healthcare industry. Many of our students are exploring career opportunities in healthcare firms, such as pharmaceutical or medical device companies, providers of healthcare services, or entrepreneurial ventures. Many also pursue opportunities in firms that service healthcare companies such as consulting firms and banks, as well as invest in such entities such as venture capital, private equity and investment management firms.
- Male: 50%
- Female: 50%
- International: 24%
- Average Years Since Undergraduate Study: 5.8
- Most Common Undergraduate Majors: Biology, Chemistry, Engineering, Public Health, Premed and other pre-professional, Economics, Business Administration, International Business, Accounting, Finance, Computer Science, Political Science, History, English, Liberal Arts and Social Sciences, Psychology
- Graduate Degrees: 28%
- Average Years of Pre-MBA Work Experience: 4.8
Guido Castagnola ’17, began his career as an MD, specialized in Psychiatry. He has treated patients with the most diverse and severe psychiatric diagnoses all across Argentina, focused on psychiatric emergencies and elder care. He did a fellowship in neuropsychiatry at INECO where he coordinated front temporal dementia protocols. His vocation of service and entrepreneurial spirit let him to co-find the Argentine Association of Tourette Syndrome, taking charge of medical advice. He simultaneously expanded his private practice primarily focused on dementias, anxiety disorders and pharmacological and psychotherapeutic control. He had his first contact with the business world as a psychiatric consultant for the Occupational Medicine departments of Unilever Argentina and Banco Frances. There he developed protocols to reduce absenteeism due to psychiatric disorders. At Columbia University, Guido was AVP of Speaker Events in the Marketing Association of Columbia and as part of his effort to improve the health system in Latin America was an active member and AVP of Events at LABA. He will be working on the IRDP of Johnson & Johnson in Buenos Aires this summer. Guido graduated as an MD from Universidad Austral of Buenos Aires, did his residency in psychiatry at the Hospital Italiano, a fellowship in neuropsychiatry at INECO and a degree in cognitive psychotherapy at CTC.
David Farkas ’17, started working as a scientist in Rochester, NY, focused on developing diagnostics technologies. Looking to build a broader understanding of the business of science he took a job with the biotechnology company MedImmune (owned by AstraZeneca), where he worked in Biopharmaceutical Development to help bring new biologic therapeutics from the lab to patients. After his first year at Columbia Business School, David holds board positions in both the Healthcare Industry Association, as VP of Entrepreneurship and Treks, and the Rugby Football Club; he is also a member of the Investment Banking and Private Equity & Venture Capital Clubs. During his first year he worked on a consulting project for Roche and over the summer he will be interning at Bank of America Merrill Lynch. David graduated from the University of Rochester with a B.S. and M.S. with Distinction in Chemistry.
Victoria Lai ’17 began her career as a healthcare consultant, working to deliver revenue cycle improvements for hospital and healthcare system clients. An interest in learning more about different segments of the healthcare industry led her to a venture capital firm in Silicon Valley, where she examined health tech investments. While at Columbia, Victoria completed two in-semester internships—one with an early stage healthcare tech startup and the other with Health Enterprise Partners, a private equity firm with a focus on healthcare. This summer, Victoria will be a Summer Associate with Goldman Sachs’ Investment Banking division. Victoria graduated from Stanford University, where she studied Human Biology.
Jamie Meyerson ’17, began her career as a management consultant, focused primarily on growth strategy and product commercialization across healthcare, manufacturing and social sector engagements. With a keen interest in health systems, Jamie left consulting to help launch the Arnhold Institute for Global Health here in New York City before joining Columbia Business School. At Columbia, Jamie is the Co-President of the Healthcare Industry Association and actively involved in the Social Enterprise Club. Jamie also supported the New York City Economic Development Corporation as an in-semester Health Strategy intern and will be working with Athenahealth this summer. Jamie graduated from Cornell University with a B.S. as a Merrill Presidential Scholar.
Morgan Shattuck ’17, began her career as an organic chemist at Norac Pharma, a contract manufacturing organization specializing in process research and development of active pharmaceutical ingredients. Morgan’s interest in the business side of the pharmaceutical industry brought her to business school at Columbia. While at CBS, Morgan is co-president of the Healthcare Industry Association and the Honor Chair for her cluster. During the school year, Morgan was an Hb Fellow at Harlem Biospace and this summer will be interning at Genentech in South San Francisco. Morgan graduated from Claremont McKenna College with a B.A. in chemistry and mathematics.